Kliničke smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom mokraćnog mjehura (CROSBI ID 300616)
Prilog u časopisu | stručni rad | domaća recenzija
Podaci o odgovornosti
Gamulin Marija, Ružić Ira Pavlović, Grgić Mislav, Jazvić Marijana, Solarić Mladen, Zahirović Dag, Zorica Robert, Omrčen Tomislav, Petković Marija, Matić Mate, Fučkar Zeljko, Ruzić Boris, Pasini Josip, Situm Marijan, Dordević Gordana, Miletić Damir, Tadić Tade, Kastelan Zeljko, Librenjak Davor, Gilja Ivan, Vilović Katarina, Kruslin Božo, Kuvezdić Hrvoje
hrvatski
Kliničke smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom mokraćnog mjehura
Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which pathohistological diagnosis is set. It is necessary to determine whether the cancer penetrated in muscle layer (muscle-invasive cancer) or not (muscle-noninvasive cancer). Decision on therapeutic modality depends on the clinical stage of disease and on prognostic and risk factors. For muscle non-invasive bladder cancer transurethral resection is preferred with or without intravesical instillation of Bacillus Calmette-Guérin (BCG). For invasive cancer the method of choice is radical cystectomy. Radiotherapy is used in radical and palliative purposes. Metastatic disease is most frequently treated by chemotherapy metotrexate/vinblastine/doxorubicine/cisplatin (MVAC) or gemcitabine/cisplatin (GC). The purpose of this article is to present clinical recommendations to set standards of procedures and criteria in diagnostics, treatment and follow up of patients with bladder cancer in the Republic of Croatia.
Rak mokraćnog mjehura, smjernice
nije evidentirano
engleski
Clinical guidelines for diagnosing, treatment and monitoring patients with bladder cancer
nije evidentirano
Bladder cancer, guideline
nije evidentirano
Podaci o izdanju
135
2013.
292-297
objavljeno
1330-4917